HR Execs on the Move

ImprimisRx

www.imprimisrx.com

 
ImprimisRx® is a pharmaceutical company dedicated to delivering high-quality and innovative medicines to physicians and patients at affordable prices. We are pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high-quality formulations that are supported by the clinical experience of physicians and their patients. We offer proprietary compounded ophthalmic formulations. All of our innovative drug formulations are born from the clinical experience of physicians and pharmacist formulators. We are focused on people, and believe our unique business model provides us with the opportunity to address unmet patient needs while delivering high quality ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.imprimisrx.com
  • 12264 El Camino Real Suite 350
    San Diego, CA USA 92130
  • Phone: 858.264.2082

Executives

Name Title Contact Details

Similar Companies

Ontario HIV Treatment Network

Ontario HIV Treatment Network is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Emeryville, CA. To find more information about Adamas Pharmaceuticals, Inc., please visit www.adamaspharma.com

Park Place Behavioral Health Care

Park Place Behavioral Health Care is a Kissimmee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

EasyRead Copywriting

EasyRead Copywriting is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.